Plant-based nutrition: Exploring health benefits for atherosclerosis, chronic diseases, and metabolic syndrome—A comprehensive review
H Peña-Jorquera, V Cid-Jofré, L Landaeta-Díaz… - Nutrients, 2023 - mdpi.com
Atherosclerosis, chronic non-communicable diseases, and metabolic syndrome are highly
interconnected and collectively contribute to global health concerns that reduce life …
interconnected and collectively contribute to global health concerns that reduce life …
Red yeast rice for the improvement of lipid profiles in mild-to-moderate hypercholesterolemia: a narrative review
Reducing low-density lipoprotein cholesterol (LDL-C) levels is a key target for lowering
cardiovascular risk and preventing atherosclerotic cardiovascular disease (ASCVD). Red …
cardiovascular risk and preventing atherosclerotic cardiovascular disease (ASCVD). Red …
[HTML][HTML] The current trend and challenges of developing red yeast rice-based food supplements for hypercholesterolemia
G Chen, W Chen, J Xu, G Ma, X Hu, G Chen - Journal of Future Foods, 2023 - Elsevier
Hypercholesterolemia is a risk factor of cardiovascular diseases, which have been managed
using statin drugs. Red yeast rice (RYR) as a traditional food in the Eastern Asia countries …
using statin drugs. Red yeast rice (RYR) as a traditional food in the Eastern Asia countries …
Changes in Key Aroma Compounds and Esterase Activity of Monascus-Fermented Cheese across a 30-Day Ripening Period
H Zeng, Y Wang, H Han, Y Cao, B Wang - Foods, 2022 - mdpi.com
Monascus-fermented cheese (MC) is a new type of mold-ripened cheese that combines a
traditional Chinese fermentation fungus, Monascus purpureus M1, with Western cheese …
traditional Chinese fermentation fungus, Monascus purpureus M1, with Western cheese …
Alternative lipid lowering strategies: State-of-the-art review of red yeast rice
L Buzzelli, A Segreti, D Di Gioia, E Lemme, MR Squeo… - Fitoterapia, 2023 - Elsevier
Red yeast rice (RYR) is an entirely natural product that originates from the fermentation of
white rice (Oryza sativa) with a yeast, mainly Monascus Purpureus, and has been part of …
white rice (Oryza sativa) with a yeast, mainly Monascus Purpureus, and has been part of …
Safety and Efficacy of the Consumption of the Nutraceutical “Red Yeast Rice Extract” for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and …
Previous studies have shown encouraging results regarding the efficacy and safety of
nutraceuticals, such as “red yeast rice (RYR) extract”, on reducing hypercholesterolemia in …
nutraceuticals, such as “red yeast rice (RYR) extract”, on reducing hypercholesterolemia in …
The activity of ten natural extracts combined in a unique blend to maintain cholesterol homeostasis—in vitro model
S Ruga, R Galla, C Penna, C Molinari… - International Journal of …, 2022 - mdpi.com
Background: Hypercholesterolemia is a major cause of cardiovascular disease and statins,
the HMGCoA inhibitors, are the most prescribed drugs. Statins reduce the production of …
the HMGCoA inhibitors, are the most prescribed drugs. Statins reduce the production of …
[HTML][HTML] Monascinol from Monascus pilosus-fermented rice exhibits hypolipidemic effects by regulating cholesterol and lipid metabolism
PX Yang, YW Hsu, TM Pan, CL Lee - Journal of Functional Foods, 2024 - Elsevier
Monascinol (Msol), a novel yellow pigment produced in red mold rice (RMR) fermented by
Monascus pilosus SWM-008, has a structure similar to monascin (MS), suggesting potential …
Monascus pilosus SWM-008, has a structure similar to monascin (MS), suggesting potential …
Bioactive plant molecules, sources, and mechanisms of action in the treatment of cardiovascular diseases
YN Clement - Pharmacognosy, 2024 - Elsevier
Cardiovascular diseases (CVDs) are leading causes of global morbidity, mortality, and
healthcare spending. The current goal of the United Nations is a 25% reduction in deaths …
healthcare spending. The current goal of the United Nations is a 25% reduction in deaths …
A scoping review on natural cholesterol lowering supplements sold in South African pharmacies
Background Dyslipidaemia is defined as elevated total or low-density lipoprotein (LDL)
levels or low levels of high-density lipoprotein (HDL). Patients may often make use of natural …
levels or low levels of high-density lipoprotein (HDL). Patients may often make use of natural …